Citigroup Inc Mirum Pharmaceuticals, Inc. Transaction History

Citigroup Inc

$153 Billion
Q2 2024

A detailed history of Citigroup Inc transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Citigroup Inc holds 212,504 shares of MIRM stock, worth $8.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

212,504

Previous 371,051 42.73%

Holding current value

$8.26 Million

Previous $9.32 Million 22.05%

% of portfolio

0.0%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$23.57 - $34.85 $3.74 Million - $5.53 Million	-158,547 Reduced 42.73%	212,504 $7.27 Million
Q1 2024 May 10, 2024	BUY	$24.92 - $30.02 $7.12 Million - $8.58 Million	285,820 Added 335.35%	371,051 $9.32 Million
Q4 2023 Feb 09, 2024	BUY	$27.14 - $34.93 $719,427 - $925,924	26,508 Added 45.14%	85,231 $2.52 Million
Q3 2023 Nov 09, 2023	BUY	$24.63 - $32.85 $441,295 - $588,573	17,917 Added 43.91%	58,723 $1.86 Million
Q2 2023 Aug 10, 2023	SELL	$23.51 - $30.09 $671,704 - $859,701	-28,571 Reduced 41.18%	40,806 $1.06 Million
Q1 2023 May 11, 2023	SELL	$19.19 - $24.1 $1.88 Million - $2.37 Million	-98,196 Reduced 58.6%	69,377 $1.67 Million
Q4 2022 Feb 09, 2023	BUY	$17.59 - $23.83 $517,269 - $700,768	29,407 Added 21.28%	167,573 $3.27 Million
Q3 2022 Nov 10, 2022	BUY	$19.98 - $29.44 $2.73 Million - $4.02 Million	136,395 Added 7701.58%	138,166 $2.9 Million
Q2 2022 Aug 10, 2022	BUY	$18.42 - $27.5 $17,793 - $26,565	966 Added 120.0%	1,771 $34,000
Q1 2022 May 12, 2022	SELL	$15.5 - $23.93 $16,104 - $24,863	-1,039 Reduced 56.34%	805 $18,000
Q4 2021 Feb 10, 2022	BUY	$13.05 - $19.35 $18,700 - $27,728	1,433 Added 348.66%	1,844 $29,000
Q3 2021 Nov 10, 2021	BUY	$13.95 - $20.18 $5,733 - $8,293	411 New	411 $8,000

Others Institutions Holding MIRM

# of Institutions

172

Shares Held

54.2M

Call Options Held

96.1K

Put Options Held

54.8K

View Full List

About Mirum Pharmaceuticals, Inc.

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.43B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

More about MIRM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account